Literature DB >> 7853984

Exacerbation of peripheral neuropathy by lamivudine.

E J Cupler, M C Dalakas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7853984     DOI: 10.1016/s0140-6736(95)90447-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Tolerability of treatments for viral hepatitis.

Authors:  A Gervais; N Boyer; P Marcellin
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Antiretroviral therapy for HIV infection. A knowledge-based approach to drug selection and use.

Authors:  G J Moyle; B G Gazzard; D A Cooper; J Gatell
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

Review 3.  Neuropsychiatric Effects of HIV Antiviral Medications.

Authors:  Glenn J Treisman; Olivia Soudry
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

Review 4.  Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection.

Authors:  C M Perry; D Faulds
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

Review 5.  Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management.

Authors:  G J Moyle; M Sadler
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

Review 6.  Neurological and psychiatric adverse effects of antiretroviral drugs.

Authors:  Michael S Abers; Wayne X Shandera; Joseph S Kass
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

7.  Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition.

Authors:  Charles E Mazzucco; Robert K Hamatake; Richard J Colonno; Daniel J Tenney
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

8.  Drosophila model of anti-retroviral therapy induced peripheral neuropathy and nociceptive hypersensitivity.

Authors:  Keegan M Bush; Kara R Barber; Jade A Martinez; Shao-Jun Tang; Yogesh P Wairkar
Journal:  Biol Open       Date:  2021-01-27       Impact factor: 2.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.